We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Agrees to Hold Off on Generic Niaspan, Advicor Until 2013
Barr Agrees to Hold Off on Generic Niaspan, Advicor Until 2013
April 14, 2005
Barr Pharmaceuticals and Kos Pharmaceuticals have reached a settlement agreement under which Barr won’t launch generic versions of Kos’ Niaspan or Advicor until 2013, unless other generic versions of the cholesterol-lowering products enter the market first.